Clinical and Experimental Immunology

Clinical and Experimental Immunology is a peer-reviewed journal published by Oxford University Press on behalf of the British Society for Immunology, established in 1966 and focused on translational and clinical immunology, with a 2025 impact factor of 3.9（Clinical and Experimental Immunology）是由 Oxford University Press 代（British Society for Immunology）出版的同行评审期刊，创刊于 1966 年，聚焦转化与临床免疫学，2025 年影响因子为 3.9。

Scope

• Translational and clinical immunology with the potential to transform the understanding of human disease immunopathology and to change clinical practice有望改变对人类疾病免疫病理认识并影响临床实践的转化与临床免疫学研究。
• Six dedicated sections, including autoimmunity and autoimmune disease, cancer immunology, immunodeficiency, and infection, infectious disease and vaccines设六个专门板块，涵盖自身免疫与自身免疫病、肿瘤免疫学、免疫缺陷，以及感染、传染病与疫苗。
• Transplantation, immune regulation and recognition, immunometabolism, innate immunity and mucosal immunology移植、免疫调节与识别、免疫代谢、固有免疫与黏膜免疫。
• Application of next-generation sequencing, metagenomics and high-dimensional phenotyping to clinical problems将下一代测序、宏基因组学与高维表型分析应用于临床问题。
• Studies in non-human model systems and reports on the physiological mechanisms of immunity as they relate to human disease非人类模型系统的研究，以及与人类疾病相关的免疫生理机制报道。

History

• The journal was established in 1966 and is among the foremost journals in translational and clinical immunology该刊创刊于 1966 年，是转化与临床免疫学领域的领先期刊之一。
• It is published by Oxford University Press on behalf of the British Society for Immunology, a not-for-profit society该刊由 Oxford University Press 代非营利性的（British Society for Immunology）出版。
• The society reinvests journal revenue into grants, events and training for the immunology community学会将期刊收益投入免疫学界的资助、会议与培训。
• Its impact factor stood at 3.4 in 2023, 3.8 in 2024 and 3.9 in 2025影响因子由 2023 年的 3.4 升至 2024 年的 3.8 与 2025 年的 3.9。

Editors

• The editor-in-chief is Professor Claudia Mauri of University College London, UK, who took up the role in January 2025 for a four-year term现任主编为（University College London）的 Claudia Mauri 教授，2025 年 1 月起任，任期四年。
• She succeeded Professor Leonie Taams, who led the journal from 2016 to 2024她的前任为 Leonie Taams 教授，任期为 2016 至 2024 年。
• The journal is structured around six sections, each led by a section editor and supported by a global editorial board drawn from academia and industry期刊设六个板块，各由一名板块编辑主持，并由来自学术界与产业界的全球编委会支持。
• Review articles are usually commissioned as review series, though suggestions to the editor-in-chief are welcome综述文章通常以综述系列形式约稿，同时欢迎向主编提出选题建议。